CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $50.5486, but opened at $47.9750. CochLear shares last traded at $47.9750, with a volume of 242 shares.
Analyst Upgrades and Downgrades
CHEOY has been the subject of several recent research reports. Jefferies Financial Group cut CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price objective on the stock. in a research report on Thursday, July 16th. Canaccord Genuity Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 18th. Finally, Zacks Research raised shares of CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Six analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $117.00.
Get Our Latest Analysis on CHEOY
CochLear Price Performance
About CochLear
Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may not receive sufficient benefit from conventional hearing aids.
The company’s portfolio includes cochlear implants, bone conduction hearing implants, and related sound processors, accessories, software and support services. Cochlear also provides rehabilitation resources, clinical support and ongoing product services intended to help recipients use and maintain their hearing systems.
Founded in 1981 and headquartered in Sydney, Australia, Cochlear serves customers through a global network spanning Australia, New Zealand, North America, Europe, Asia and other international markets.
Recommended Stories
- Five stocks we like better than CochLear
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
